unyango lwe-renal cell carcinoma pathology

Unyango lwe-Renal Cell Carcinoma: Umbono wePathology

Esi sikhokelo esibanzi sihlola i-pathology ye-renal cell carcinoma (RCC), ihlolisise kwiintlobo zayo ezahlukeneyo, iindlela zokuxilonga, kunye neziphumo zezicwangciso zonyango. Sivavanya iimpawu ze-microscopic, ukuguqulwa kofuzo, kunye neemeko ze-prognostic ezinxulumene ne-RCC, ukubonelela ngokuqonda okucacileyo kubasebenzi bezempilo kunye nabaphandi.

Ukuqonda iRenal Cell Carcinoma

Ukuchaza i-RCC kunye neSubtypes zayo

I-Renal cell carcinoma, olona hlobo luxhaphakileyo lomhlaza wezintso, luqala kunwebu lwezintso. Kukho ii-subtypes ezininzi, nganye ineempawu ezahlukileyo ze-pathological kunye nokuziphatha kweklinikhi. Ezi ziquka i-cell cell RCC (ccRCC), i-papillary RCC (pRCC), i-chromophobe RCC (chRCC), kunye nabanye. Uchwethezo oluchanekileyo oluchanekileyo lubalulekile kwisikhokelo unyango lwe-renal cell carcinoma pathology kunye nokuqikelela i-prognosis. Ulwahlulo oluchanekileyo luxhomekeke kuvavanyo lwe-microscopic ngononophelo kunye ne-immunohistochemical staining, ehlala ifuna ubuchule kwi-genitourinary pathology.

Iimpawu zeMicroscopic kunye neMithetho yokuHlola

Ukuxilongwa kwe-RCC kusekelwe ikakhulu kuvavanyo lwe-histopathological yeesampulu zethishu ezifunyenwe nge-biopsy okanye uqhaqho loqhaqho. Iimpawu ezithile zemicroscopic, ezifana ne-cell morphology, iimpawu zenyukliya, kunye neepateni zokukhula, zinceda ukwahlula phakathi kwe-RCC subtypes. Ngokomzekelo, i-ccRCC ibonakaliswe nge-cytoplasm ecacileyo, ngelixa i-pRCC ibonisa i-papillary architecture. I-Immunohistochemistry idlala indima ebalulekileyo ekuqinisekiseni ukuxilongwa kunye nokuchonga i-subtypes ethile, inceda ukucokisa. unyango lwe-renal cell carcinoma pathology izicwangciso.

Ukuguqulwa kweGenetic kunye ne-Molecular Pathology

Indima yeGenetics kuPhuhliso lweRCC

Ukungahambi kakuhle kwemfuza kudlala indima ebalulekileyo kuphuhliso kunye nokuqhubela phambili kwe-RCC. Olona tshintsho luqhelekileyo lwemfuza lubandakanya i-von Hippel-Lindau (VHL) i-tumor suppressor gene, ngakumbi kwi-ccRCC. Ezinye iijini, ezifana ne-PBRM1, BAP1, kunye ne-SETD2, nazo zisoloko zitshintshwa kwiintlobo ezincinci ze-RCC. Ukuqonda olu tshintsho lwemfuza kubalulekile ekuphuhliseni unyango olujoliswe kuyo kunye nokuphucula iziphumo zezigulane. Ubuchule obukwinqanaba eliphezulu lemolekyuli, njengolandelelwano lwesizukulwana esilandelayo, zisetyenziswa kakhulu ukuchonga olu tshintsho, ukwazisa unyango lwe-renal cell carcinoma pathology ukusondela.

Iimpembelelo kuNyango oluJolisiweyo

Ukuchongwa kweenguqu ezithile zofuzo kwi-RCC kuye kwakhokelela ekuphuhliseni unyango olujoliswe kuyo. Ngokomzekelo, i-inhibitors ye-vascular endothelial growth factor (VEGF) kunye nethagethi ye-mammalian ye-rapamycin (mTOR) isetyenziswa ngokuqhelekileyo kwi-RCC ephezulu, ngakumbi ezo zineenguqu ze-VHL. Ezi arhente zijoliswe kuzo zihlala zibonisa inzuzo ebalulekileyo yekliniki kunye nokuphucula amazinga okuphila. Uphando oluqhubekayo kwi-molecular underpinnings ye-RCC iyaqhubeka nokuvula indlela yonyango olujoliswe kuyo olusebenzayo kunye nezicwangciso zonyango lomntu ngamnye.

Imiba yePrognostic kunye neZicwangciso zoNyango

Ukuqikelela i-Prognosis kunye noKhetho loNyango

Izinto ezininzi zinefuthe kwi-prognosis ye-RCC, kubandakanya i-tumor stage, ibakala, kunye ne-subtype. Ubukho besifo semetastatic buchaphazela kakhulu amazinga okusinda. Iimpawu ze-pathological, ezifana nebakala lenyukliya kunye ne-necrosis, nazo zinegalelo ekuqikeleleni koxinzelelo. Olu vavanyo luneenkcukacha lwe-pathological luyimfuneko ekukhokeleni izigqibo zonyango kunye nokulungelelanisa iindlela zonyango kwizigulane ngamnye. Ukhetho lwe unyango lwe-renal cell carcinoma pathology kuxhomekeke kakhulu kolu vavanyo.

Iinketho zonyango kunye nesiseko sazo sePathological

Izicwangciso zonyango lwe-RCC ziyahluka ngokuxhomekeke kwinqanaba kunye nebakala lesi sifo. Uqhaqho loqhaqho lolona nyango luphambili kwi-RCC yendawo. Kwi-RCC ephezulu okanye ye-metastatic, unyango lwenkqubo olufana nee-agent ezijoliswe kuyo okanye i-immunotherapy ziqeshwe. Ukhetho lonyango luhlala lukhokelwa yi-pathological subtype, ukuguqulwa kofuzo, kunye nempilo yonke yesigulane. Uphando oluqhubelekayo luphonononga iindlela ezintsha zonyango, sikhulisa ukuqonda kwethu iindlela zemolekyuli eziqhuba uphuhliso lweRCC.

Ubuchwephesha obukwinqanaba eliphezulu kwi-RCC Pathology

Immunohistochemistry kunye nezicelo zayo

I-Immunohistochemistry (IHC) sisixhobo esixabisekileyo kwi-RCC pathology. Iimpawu ezithile, ezifana ne-VHL, i-AMACR, kunye ne-PAX8, zisetyenziselwa ukuchonga i-RCC subtypes kwaye zihluke kwezinye izidumbu zezintso. I-IHC inokunceda kwakhona ekuvavanyeni ibakala le-tumor kunye nokuxela kwangaphambili i-prognosis. Ngaphaya koko, i-IHC idlala indima ebalulekileyo ekuchongeni iithagethi ezinokubakho zonyango, ukwazisa umntu ngamnye. unyango lwe-renal cell carcinoma pathology izigqibo.

IiTekhnoloji zePathology yeMolekyuli

Ubuchule obuphezulu bemolekyuli, obufana nolandelelwano lwesizukulwana esilandelayo (NGS) kunye ne-fluorescence in situ hybridization (FISH), ziya zisetyenziswa ngakumbi kwi-RCC pathology. I-NGS ivumela iprofayili ebanzi ye-genomic, ukuchonga uluhlu olubanzi lweenguqu zofuzo ezinokuchaphazela ukhetho lonyango kunye nokuqikelela impendulo kunyango. I-FISH inokubona izinto ezingaqhelekanga zechromosomal, inika ulwazi olongezelelweyo kwi-tumor biology kunye ne-prognosis.

Le ngcaciso inikwe apha yeyokufundisa kuphela kwaye ayiquki iingcebiso zonyango. Ukuxilongwa kunye nonyango lwe-renal cell carcinoma, nceda udibane nochwepheshe bezempilo abaqeqeshiweyo.

Ngolwazi oluthe vetshe kunye nenkxaso, cinga ngokundwendwela i IZiko loPhando ngoMhlaza laseShandong Baofa iwebhusayithi. Banikezela ngezibonelelo ezixabisekileyo kunye nobuchule kukhathalelo lomhlaza.